Company
BB Biotech AG
Headquarters: Kusnacht, Switzerland
Employees: 10
Market Cap
CHF1.94 Billion
CHF as of Jan. 1, 2025
US$2.14 Billion
BB Biotech AG Categories
Switzerland Healthcare BiotechnologySwitzerland Healthcare Switzerland Biotechnology
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $622.07 B |
| Vertex Pharmaceuticals Incorporated | $113.24 B |
| CSL Limited | $95.75 B |
| Regeneron Pharmaceuticals, Inc. | $76.33 B |
| Marinomed Biotech AG | $56.13 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Financials
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | CHF-199,567,000 |
| EBITDA | CHF0 |
| Gross Profit TTM | CHF0 |
| Profit Margin | % |
| Operating Margin | % |
| Quarterly Revenue Growth | 88.68% |
Stocks & Indices
BB Biotech AG has the following listings and related stock indices.
Stock: SIX: BION wb_incandescent
Stock: MTA: BB wb_incandescent
Stock: OTC: BBAGF wb_incandescent